Astellas announced it raked in $8 billion between April 1 and December 31 2023 – a $166.3 million increase over that same period in 2022 – during their earnings report today. While they make billions, Americans pay exorbitantly high prices for prescription drugs. Astellas opposed the Biden administration reforms that lower prescription drug prices.
Over 2023, Astellas rewarded its sharehold...
Please log in to access subscriber content.
If you don't have a subscription, click
here for a WisPolitics free trial and to view the different subscription options.
